{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:36:50Z","timestamp":1782995810077,"version":"3.54.5"},"reference-count":110,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Thrombotic microangiopathy (TMA) encompasses a range of disorders characterized by blood clotting in small blood vessels, leading to organ damage. It can manifest as various syndromes, including thrombotic thrombocytopenic purpura (TTP), hemolytic-uremic syndrome (HUS), and others, each with distinct causes and pathophysiology. Thrombo-inflammation plays a significant role in TMA pathogenesis: inflammatory mediators induce endothelial injury and activation of platelet and coagulation cascade, contributing to microvascular thrombosis. Primary TMA, such as TTP, is primarily caused by deficient ADAMTS13 metalloproteinase activity, either due to antibody-mediated inhibition or intrinsic enzyme synthesis defects. In cancer patients, a significant reduction in ADAMTS13 levels and a corresponding increase in VWF levels is observed. Chemotherapy further decreased ADAMTS13 levels and increased VWF levels, leading to an elevated VWF\/ADAMTS13 ratio and increased thrombotic risk. Drug-induced TMA (DITMA) can result from immune-mediated or non-immune-mediated mechanisms. Severe cases of COVID-19 may lead to a convergence of syndromes, including disseminated intravascular coagulation (DIC), systemic inflammatory response syndrome (SIRS), and TMA. Treatment of TMA involves identifying the underlying cause, implementing therapies to inhibit complement activation, and providing supportive care to manage complications. Plasmapheresis may be beneficial in conditions like TTP. Prompt diagnosis and treatment are crucial to prevent serious complications and improve outcomes.<\/jats:p>","DOI":"10.3390\/ijms25169055","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T05:16:24Z","timestamp":1724649384000},"page":"9055","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Phenomenon of Thrombotic Microangiopathy in Cancer Patients"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4509-9281","authenticated-orcid":false,"given":"Alexander","family":"Vorobev","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Bitsadze","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidan","family":"Yagubova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0725-9686","authenticated-orcid":false,"given":"Jamilya","family":"Khizroeva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Solopova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tretyakova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-4477","authenticated-orcid":false,"given":"Nilufar","family":"Gashimova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Grigoreva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0732-6808","authenticated-orcid":false,"given":"Sabina","family":"Einullaeva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1742-6264","authenticated-orcid":false,"given":"Maria","family":"Drozhzhina","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, Russian University of Medicine, 4th Dolgorukovskaya Str., 127006 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aygun","family":"Hajiyeva","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, I.M. Sechenov First State Moscow Medical University Baku Branch, Huseyn Javid, Yasamal, Baku AZ1141, Azerbaijan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Khalilulina","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, Pirogov Russian National Research Medical University, Ulitsa Ostrovityanova 1, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7971-7711","authenticated-orcid":false,"given":"Alexander","family":"Cherepanov","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daredzhan","family":"Kapanadze","sequence":"additional","affiliation":[{"name":"Center of Pathology of Pregnancy and Hemostasis \u00abMedlabi\u00bb, 340112 Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Egorova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2754-5129","authenticated-orcid":false,"given":"Nart","family":"Kuneshko","sequence":"additional","affiliation":[{"name":"Moscow\u2019s Region Odintsovo Maternity Hospital, 143003 Odintsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-9910","authenticated-orcid":false,"given":"Jean-Christophe","family":"Gris","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"},{"name":"Faculty of Pharmaceutical and Biological Sciences, Montpellier University, 34093 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Elalamy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"},{"name":"Department Hematology and Thrombosis Center, Medicine Sorbonne University, 75012 Paris, France"},{"name":"Hospital Tenon, 4 Rue de la Chine, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"},{"name":"Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, 1080 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Makatsariya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Val\u00e9rio, P., Barreto, J.P., Ferreira, H., Chuva, T., Paiva, A., and Costa, J.M. (2021). Thrombotic microangiopathy in oncology\u2014A review. Transl. Oncol., 14.","DOI":"10.1016\/j.tranon.2021.101081"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Pint\u00f3, I., Espinosa, G., and Cervera, R. (2015). Catastrophic APS in the context of other thrombotic microangiopathies. Curr. Rheumatol. Rep., 17.","DOI":"10.1007\/s11926-014-0482-z"},{"key":"ref_5","first-page":"21","article-title":"Hyaline thrombosis of the terminal arterioles and capillaries: A hitherto undescribed disease","volume":"24","author":"Moschcowitz","year":"1924","journal-title":"Proc. N. Y. Pathol. Soc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood.V2.6.542.542","article-title":"Thrombotic thrombocytopenic purpura; hemorrhagic diathesis with generalized platelet thromboses","volume":"2","author":"Singer","year":"1947","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine"},{"key":"ref_8","first-page":"105","article-title":"Thrombotic thrombocytopenic purpura: Understanding a disease no longer rare","volume":"316","author":"Moake","year":"1998","journal-title":"Am. J. Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor\u2013cleaving protease","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a003009","article-title":"A novel human metalloprotease synthesized in the liver and secreted into the blood: Possibly, the von Willebrand factor-cleaving protease?","volume":"130","author":"Soejima","year":"2001","journal-title":"J. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of human von Willebrand factor\u2013cleaving protease and its identification as a new member of the metalloproteinase family","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.7326\/0003-4819-51-6-1409","article-title":"Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions","volume":"51","author":"Rubinstein","year":"1959","journal-title":"Ann. Intern. Med."},{"key":"ref_17","first-page":"178","article-title":"The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange","volume":"24","author":"Shepard","year":"1987","journal-title":"Semin. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ckj\/sfz040","article-title":"An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy","volume":"12","author":"Aigner","year":"2019","journal-title":"Clin. Kidney J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Abou-Ismail, M.Y., Kapoor, S., Citla Sridhar, D., Nayak, L., and Ahuja, S. (2022). Thrombotic microangiopathies: An illustrated review. Res. Pract. Thromb. Haemost., 6.","DOI":"10.1002\/rth2.12708"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.preghy.2018.02.007","article-title":"Thrombotic microangiopathies of pregnancy: Differential diagnosis","volume":"12","author":"Gupta","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000527553","article-title":"The Challenging Management of Acute Thrombotic Microangiopathy in Pregnancy","volume":"146","author":"Marques","year":"2023","journal-title":"Acta Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bitsadze, V.O., Khizroeva, J., and Makatsariya, A.D. (2017). The acquired form of ADAMTS-13 deficiency as the cause of thrombotic microangiopathy in a pregnant woman with recurrent cerebral circulation disorders, venous thromboembolism, preeclampsia and fetal loss syndrome. Case Rep. Perinat. Med., 6.","DOI":"10.1515\/crpm-2017-0023"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17749\/2070-4968.2015.9.2.062-71","article-title":"Thrombotic micro- angiopathy in the pathogenesis of obstetric complications","volume":"9","author":"Akinshina","year":"2015","journal-title":"Akusherstvo Ginekol. i Reproduktsiia"},{"key":"ref_25","first-page":"18","article-title":"Thrombotic microangiopathy and pregnancy","volume":"85","author":"Toman","year":"2020","journal-title":"Ceska Gynekol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/AOG.0000000000005024","article-title":"Differentiating and Managing Rare Thrombotic Microangiopathies during Pregnancy and Postpartum","volume":"141","author":"Lim","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/hematology.2021000290","article-title":"How to evaluate and treat the spectrum of TMA syndromes in pregnancy","volume":"2021","author":"Scully","year":"2021","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: Report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.34067\/KID.0000000000000061","article-title":"Chemotherapy-Associated Thrombotic Microangiopathy","volume":"4","author":"Aklilu","year":"2023","journal-title":"Kidney360"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.0000000000000182","article-title":"Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies","volume":"18","author":"Werion","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2215\/CJN.11470918","article-title":"Etiology and Outcomes of Thrombotic Microangiopathies","volume":"14","author":"Bayer","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Henry, N., Mellaza, C., Fage, N., Beloncle, F., Genevieve, F., Legendre, G., Orvain, C., Garnier, A.-S., Cousin, M., and Besson, V. (2021). Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study. Front. Med., 8.","DOI":"10.3389\/fmed.2021.566678"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ackd.2021.11.006","article-title":"Thrombotic Microangiopathy Syndromes\u2014Common Ground and Distinct Frontiers","volume":"29","author":"Hanna","year":"2022","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.amjmed.2020.06.020","article-title":"Cardiovascular Complications and Their Association with Mortality in Patients with Thrombotic Thrombocytopenic Purpura","volume":"134","author":"Balasubramaniyam","year":"2021","journal-title":"Am. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chatzikonstantinou, T., Gavriilaki, M., Anagnostopoulos, A., and Gavriilaki, E. (2020). An Update in Drug-Induced Thrombotic Microangiopathy. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00212"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Timmermans, S.A.M.E.G., and van Paassen, P. (2021). The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation. J. Clin. Med., 10.","DOI":"10.3390\/jcm10143034"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00063-016-0176-6","article-title":"Thrombotische Mikroangiopathien: Relevante Neuigkeiten f\u00fcr den Intensivmediziner [Thrombotic microangiopathy: Relevant new aspects for intensive care physicians]","volume":"111","author":"Gaggl","year":"2016","journal-title":"Med. Klin. Intensivmed. Notfmed."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ijlh.13954","article-title":"Diagnosis and treatment of thrombotic microangiopathy","volume":"44","author":"Thompson","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.medcli.2019.01.020","article-title":"Thrombotic thrombocytopenic purpura in a patient with metastatic lung cancer","volume":"153","author":"Doello","year":"2019","journal-title":"Med. Clin."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3324\/haematol.2021.279484","article-title":"Treatment of drug-induced immune thrombocytopenias","volume":"107","author":"Marini","year":"2022","journal-title":"Haematologica"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Manabe, M., Inano, N., Hagiwara, Y., Sogabe, N., Nanno, S., Mazaki, T., and Koh, K.-R. (2024). Cancer-related thrombotic microangiopathy and disseminated intravascular coagulation in a patient with bone marrow carcinomatosis of unknown primary origin: A case report. Cancer Rep., 7.","DOI":"10.1002\/cnr2.2036"},{"key":"ref_42","first-page":"323","article-title":"Thrombotic microangiopathy in cancer patients","volume":"74","author":"Makatsariya","year":"2019","journal-title":"Ann. Russ. Acad. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hellenthal, K.E.M., Brabenec, L., and Wagner, N.-M. (2022). Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation. Cells, 11.","DOI":"10.3390\/cells11121935"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yee, P.P., and Li, W. (2021). Tumor necrosis: A synergistic consequence of metabolic stress and inflammation. BioEssays, 43.","DOI":"10.1002\/bies.202100029"},{"key":"ref_45","first-page":"964","article-title":"Goodpasture syndrome and anti-glomerular basement membrane disease","volume":"41","author":"Reggiani","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.28996\/2618-9801-2023-4-465-492","article-title":"Clinical guidelines for the management of adult patients with atypical hemolytic-uremic syndrome","volume":"25","author":"Kozlovskaya","year":"2023","journal-title":"Nephrol. Dialysis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1024\/1661-8157\/a003927","article-title":"CME: Notfallmanagement der thrombotischen Mikroangiopathie [CME: Diagnostic Approach and Management of Thrombotic Microangiopathy]","volume":"111","author":"Sutter","year":"2022","journal-title":"Praxis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1182\/blood.2019003810","article-title":"How I treat microangiopathic hemolytic anemia in patients with cancer","volume":"137","author":"Thomas","year":"2021","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/09537104.2022.2026912","article-title":"The utility of platelet activation biomarkers in thrombotic microangiopathies","volume":"33","author":"Qiao","year":"2022","journal-title":"Platelets"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2022.08.029","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury\u2014A systematic review","volume":"536","author":"Marakala","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-030-20315-3_10","article-title":"Microangiopathy in Cancer: Causes, Consequences, and Management","volume":"179","author":"Thomas","year":"2019","journal-title":"Cancer Treat. Res."},{"key":"ref_52","unstructured":"Stanley, M., Killeen, R.B., and Michalski, J.M. (2024). Thrombotic Thrombocytopenic Purpura. StatPearls [Internet], StatPearls Publishing. Updated 7 April 2023."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Sukumar, S., L\u00e4mmle, B., and Cataland, S.R. (2021). Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030536"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/jth.15822","article-title":"ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura","volume":"20","author":"Halkidis","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Nusrat, S., Beg, K., Khan, O., Sinha, A., and George, J. (2023). Hereditary Thrombotic Thrombocytopenic Purpura. Genes, 14.","DOI":"10.3390\/genes14101956"},{"key":"ref_56","unstructured":"Umerah, C.O., and Momodu, I.I. (2024). Anticoagulation. StatPearls [Internet], StatPearls Publishing. Updated 17 July 2023."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Okhota, S., Melnikov, I., Avtaeva, Y., Kozlov, S., and Gabbasov, Z. (2020). Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207804"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Mojzisch, A., and Brehm, M.A. (2021). The Manifold Cellular Functions of von Willebrand Factor. Cells, 10.","DOI":"10.3390\/cells10092351"},{"key":"ref_59","unstructured":"Ameer, M.A., Wasey, A., and Salen, P. (2024). Escherichia coli (e Coli 0157 H7). StatPearls [Internet], StatPearls Publishing. Updated 8 August 2023."},{"key":"ref_60","unstructured":"Bhandari, J., Rout, P., and Sedhai, Y.R. (2024). Hemolytic Uremic Syndrome. StatPearls [Internet], StatPearls Publishing. Updated 19 October 2023."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/1744-9987.12763","article-title":"Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment","volume":"23","author":"Raina","year":"2019","journal-title":"Ther. Apher. Dial."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kuijpers, M.J.E., Heemskerk, J.W.M., and Jurk, K. (2022). Molecular Mechanisms of Hemostasis, Thrombosis and Thrombo-Inflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105825"},{"key":"ref_63","first-page":"84","article-title":"Pathogenic aspects of interaction between the tumor tissue and hemostatic system","volume":"10","author":"Makatsariya","year":"2016","journal-title":"Obstet. Gynecol. Reprod."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"755","DOI":"10.17749\/2313-7347\/ob.gyn.rep.2021.274","article-title":"Platelets, thrombo-inflammation and cancer","volume":"15","author":"Slukhanchuk","year":"2021","journal-title":"Obstet. Gynecol. Reprod."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1182\/blood-2015-12-688747","article-title":"Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: A potential link of inflammation to TTP","volume":"128","author":"Pillai","year":"2016","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","article-title":"Inflammation, von Willebrand factor, and ADAMTS13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1080\/14767058.2020.1786811","article-title":"Thrombotic microangiopathy, DIC-syndrome and COVID-19: Link with pregnancy prothrombotic state","volume":"35","author":"Makatsariya","year":"2022","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/nep.14225","article-title":"COVID-19 associated thrombotic microangiopathy","volume":"28","author":"Cebi","year":"2023","journal-title":"Nephrology"},{"key":"ref_69","first-page":"32","article-title":"Thrombotic Microangiopathy in Patients Recovering from COVID-19","volume":"24","year":"2022","journal-title":"MEDICC Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"England, J.T., Abdulla, A., Biggs, C.M., Lee, A.Y., Hay, K.A., Hoiland, R.L., Wellington, C.L., Sekhon, M., Jamal, S., and Shojania, K. (2021). Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes. Blood Rev., 45.","DOI":"10.1016\/j.blre.2020.100707"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Karakike, E., and Giamarellos-Bourboulis, E.J. (2019). Macrophage activation-like syndrome: A distinct entity leading to early death in sepsis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00055"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Crayne, C.B., Albeituni, S., Nichols, K.E., and Cron, R.Q. (2019). The immunology of macrophage activation syndrome. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00119"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Serrano, M., Espinosa, G., Serrano, A., and Cervera, R. (2022). COVID-19 and the antiphospholipid syndrome. Autoimmun. Rev., 21.","DOI":"10.1016\/j.autrev.2022.103206"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Zulfiqar, A.-A., Lorenzo-Villalba, N., Hassler, P., and Andr\u00e8s, E. (2020). Immune thrombocytopenic purpura in a patient with COVID-19. N. Engl. J. Med., 382.","DOI":"10.1056\/NEJMc2010472"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nm.2262","article-title":"Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes","volume":"17","author":"Monsalvo","year":"2011","journal-title":"Nat. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-009-0209-x","article-title":"Platelets and viruses: An ambivalent relationship","volume":"67","author":"Flaujac","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1111\/jth.12977","article-title":"Extracellular DNA and histones: Double-edged swords in immunothrombosis","volume":"13","author":"Gould","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Saffarzadeh, M., Juenemann, C., Queisser, M.A., Lochnit, G., Barreto, G., Galuska, S.P., Lohmeyer, J., and Preissner, K.T. (2012). Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032366"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jcp.25887","article-title":"A biophysical view on von Willebrand factor activation","volume":"233","author":"Brehm","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/bloodadvances.2018030122","article-title":"von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain","volume":"3","author":"Zhang","year":"2019","journal-title":"Blood Adv."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jth.14981","article-title":"COVID-19: A collision of complement, coagulation and inflammatory pathways","volume":"18","author":"Chauhan","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1537-2995.2007.01266.x","article-title":"Protein A immunoadsorption therapy for refractory, mitomycin C\u2013associated thrombotic microangiopathy","volume":"47","author":"Kasper","year":"2007","journal-title":"Transfusion"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Khaja, M., Qureshi, Z.A., Kandhi, S., Altaf, F., and Yapor, L. (2022). Mitomycin-Induced Thrombotic Thrombocytopenic Purpura Treated Successfully with Plasmapheresis and Steroid: A Case Report. Cureus, 14.","DOI":"10.7759\/cureus.23525"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1002\/ajh.27101","article-title":"Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database","volume":"98","author":"Klomjit","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine-induced thrombotic microangiopathy: A systematic review","volume":"21","author":"Izzedine","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/107327481702400108","article-title":"Thrombotic microangiopathy in a patient treated with gemcitabine","volume":"24","author":"Nanjappa","year":"2017","journal-title":"Cancer Control"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1470-2045(07)70203-6","article-title":"Gemcitabine-associated thrombotic thrombocytopenic purpura","volume":"8","author":"Zupancic","year":"2007","journal-title":"Lancet Oncol."},{"key":"ref_91","unstructured":"Zanchelli, F., Tampieri, E., Gozzetti, F., Monti, M., Martelli, D., Graziani, R., Zuffa, E., Vincenzi, D., Gamboni, A., and Buscaroli, A. (2017). Atypical hemolytic uremic syndrome related to Oxalyplatin cancer chemotherapy responsive to Eculizumab. G. Ital. Nefrol., 34, (In Italian)."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/1097-0142(19890901)64:5<1017::AID-CNCR2820640508>3.0.CO;2-N","article-title":"Carboplatin-associated thrombotic microangiopathic hemolytic anemia","volume":"64","author":"Walker","year":"1989","journal-title":"Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Saad, R., Hannun, A., Temraz, S., Finianos, A., and Zeenny, R.M. (2022). Oxaliplatin-induced thrombotic microangiopathy: A case report. J. Med. Case Rep., 16.","DOI":"10.1186\/s13256-022-03309-7"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.nephro.2017.01.016","article-title":"Thrombotic microangiopathies and antineoplastic agents","volume":"13","author":"Coppo","year":"2017","journal-title":"Nephrol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00063-022-00984-8","article-title":"Thrombotische Mikroangiopathien [Thrombotic microangiopathy]","volume":"118","author":"Schmidt","year":"2023","journal-title":"Med. Klin. Intensivmed. Notfmed."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/art.42681","article-title":"Clinical Evaluation and Management of Thrombotic Microangiopathy","volume":"76","author":"Leisring","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Mazzierli, T., Allegretta, F., Maffini, E., and Allinovi, M. (2023). Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1088031"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.2020007206","article-title":"Complement and the prothrombotic state","volume":"139","author":"Schmidt","year":"2022","journal-title":"Blood"},{"key":"ref_99","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (1993\u20132024). Genetic Atypical Hemolytic-Uremic Syndrome. GeneReviews\u00ae [Internet], University of Washington. 16 November 2007 [pdated 23 September 2021]."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Sheridan, D., Yu, Z.-X., Zhang, Y., Patel, R., Sun, F., Lasaro, M.A., Bouchard, K., Andrien, B., Marozsan, A., and Wang, Y. (2018). Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195909"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.kint.2020.10.046","article-title":"The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome na\u00efve to complement inhibitor treatment","volume":"100","author":"Ariceta","year":"2021","journal-title":"Kidney Int."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.thromres.2023.02.012","article-title":"Eculizumab in the management of drug-induced thrombotic microangiopathy: A scoping review of the literature","volume":"224","author":"Zafar","year":"2023","journal-title":"Thromb. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40620-016-0288-3","article-title":"Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment","volume":"30","author":"Walle","year":"2017","journal-title":"J. Nephrol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Menne, J., Delmas, Y., Fakhouri, F., Licht, C., Lommel\u00e9, \u00c5., Minetti, E.E., Prov\u00f4t, F., Rondeau, E., Sheerin, N.S., and Wang, J. (2019). Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1314-1"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.06440616","article-title":"Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation","volume":"12","author":"Fakhouri","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12185-022-03495-6","article-title":"The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: An open-label phase 2\/3 study","volume":"117","author":"Miyakawa","year":"2023","journal-title":"Int. J. Hematol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12185-023-03657-0","article-title":"Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023","volume":"118","author":"Matsumoto","year":"2023","journal-title":"Int. J. Hematol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ajh.23527","article-title":"ADAMTS13 content in plasma-derived factor VIII\/von Willebrand factor concentrates","volume":"88","author":"Peyvandi","year":"2013","journal-title":"Am. J. Hematol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","article-title":"Recombinant ADAMTS-13: First-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura","volume":"130","author":"Scully","year":"2017","journal-title":"Blood"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","article-title":"Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura","volume":"390","author":"Scully","year":"2024","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9055\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:40:10Z","timestamp":1760110810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":110,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25169055"],"URL":"https:\/\/doi.org\/10.3390\/ijms25169055","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}